235 related articles for article (PubMed ID: 36657992)
21. Synuclein-One study: skin biopsy detection of phosphorylated α-synuclein for diagnosis of synucleinopathies.
Gibbons CH; Freeman R; Bellaire B; Adler CH; Moore D; Levine T
Biomark Med; 2022 May; 16(7):499-509. PubMed ID: 35272481
[TBL] [Abstract][Full Text] [Related]
22. Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy.
Mori F; Piao YS; Hayashi S; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
J Neuropathol Exp Neurol; 2003 Aug; 62(8):812-9. PubMed ID: 14503637
[TBL] [Abstract][Full Text] [Related]
23. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
[TBL] [Abstract][Full Text] [Related]
24. Skin nerve α-synuclein deposits: a biomarker for idiopathic Parkinson disease.
Donadio V; Incensi A; Leta V; Giannoccaro MP; Scaglione C; Martinelli P; Capellari S; Avoni P; Baruzzi A; Liguori R
Neurology; 2014 Apr; 82(15):1362-9. PubMed ID: 24634456
[TBL] [Abstract][Full Text] [Related]
25. The aggregation state of α-synuclein deposits in dermal nerve fibers of patients with Parkinson's disease resembles that in the brain.
Kuzkina A; Schulmeyer L; Monoranu CM; Volkmann J; Sommer C; Doppler K
Parkinsonism Relat Disord; 2019 Jul; 64():66-72. PubMed ID: 30902527
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylated α-synuclein in skin nerve fibres differentiates Parkinson's disease from multiple system atrophy.
Zange L; Noack C; Hahn K; Stenzel W; Lipp A
Brain; 2015 Aug; 138(Pt 8):2310-21. PubMed ID: 26017579
[TBL] [Abstract][Full Text] [Related]
27. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular autonomic nervous system evaluation in Parkinson disease and multiple system atrophy.
Brisinda D; Sorbo AR; Di Giacopo R; Venuti A; Bentivoglio AR; Fenici R
J Neurol Sci; 2014 Jan; 336(1-2):197-202. PubMed ID: 24267739
[TBL] [Abstract][Full Text] [Related]
29. The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson's disease.
Lau HHC; Martinez-Valbuena I; So RWL; Mehra S; Silver NRG; Mao A; Stuart E; Schmitt-Ulms C; Hyman BT; Ingelsson M; Kovacs GG; Watts JC
Acta Neuropathol Commun; 2023 May; 11(1):72. PubMed ID: 37138318
[TBL] [Abstract][Full Text] [Related]
30. Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies.
Krismer F; Jellinger KA; Scholz SW; Seppi K; Stefanova N; Antonini A; Poewe W; Wenning GK
Parkinsonism Relat Disord; 2014 Aug; 20(8):793-9. PubMed ID: 24894118
[TBL] [Abstract][Full Text] [Related]
31. The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies.
Leys F; Wenning GK; Fanciulli A
Neurol Sci; 2022 Jan; 43(1):187-198. PubMed ID: 34817726
[TBL] [Abstract][Full Text] [Related]
32. Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis.
Sako W; Murakami N; Izumi Y; Kaji R
Mov Disord; 2014 Nov; 29(13):1599-605. PubMed ID: 25258345
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous Alpha-Synuclein From Paraffin Embedded Autopsy Specimens in Parkinson's Disease.
Gibbons CH; Wang N; Freeman R
J Parkinsons Dis; 2017; 7(3):503-509. PubMed ID: 28582870
[TBL] [Abstract][Full Text] [Related]
34. Clinical Utility of Skin Biopsy in Differentiating between Parkinson's Disease and Multiple System Atrophy.
Haga R; Sugimoto K; Nishijima H; Miki Y; Suzuki C; Wakabayashi K; Baba M; Yagihashi S; Tomiyama M
Parkinsons Dis; 2015; 2015():167038. PubMed ID: 25945280
[TBL] [Abstract][Full Text] [Related]
35. Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy.
Kao AW; Racine CA; Quitania LC; Kramer JH; Christine CW; Miller BL
Alzheimer Dis Assoc Disord; 2009; 23(4):365-70. PubMed ID: 19935145
[TBL] [Abstract][Full Text] [Related]
36. Is Multiple System Atrophy a Prion-like Disorder?
Jellinger KA; Wenning GK; Stefanova N
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576255
[TBL] [Abstract][Full Text] [Related]
37. Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure.
Lipp A; Sandroni P; Ahlskog JE; Fealey RD; Kimpinski K; Iodice V; Gehrking TL; Weigand SD; Sletten DM; Gehrking JA; Nickander KK; Singer W; Maraganore DM; Gilman S; Wenning GK; Shults CW; Low PA
Arch Neurol; 2009 Jun; 66(6):742-50. PubMed ID: 19506134
[TBL] [Abstract][Full Text] [Related]
38. Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy.
Martinez-Valbuena I; Visanji NP; Kim A; Lau HHC; So RWL; Alshimemeri S; Gao A; Seidman MA; Luquin MR; Watts JC; Lang AE; Kovacs GG
Transl Neurodegener; 2022 Feb; 11(1):7. PubMed ID: 35125105
[TBL] [Abstract][Full Text] [Related]
39. Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories.
Bargar C; De Luca CMG; Devigili G; Elia AE; Cilia R; Portaleone SM; Wang W; Tramacere I; Bistaffa E; Cazzaniga FA; Felisati G; Legname G; Di Fonzo A; Xu R; Gunzler SA; Giaccone G; Eleopra R; Chen SG; Moda F
Mol Neurodegener; 2021 Dec; 16(1):82. PubMed ID: 34895275
[TBL] [Abstract][Full Text] [Related]
40. Alpha-synuclein in gastric and colonic mucosa in Parkinson's disease: Limited role as a biomarker.
Chung SJ; Kim J; Lee HJ; Ryu HS; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Lee JY; Hong SM; Myung SJ
Mov Disord; 2016 Feb; 31(2):241-9. PubMed ID: 26686342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
